-
Major Psychedelics Firm Is Studying Magic Mushrooms To Treat Meth Addiction
Friday, September 16, 2022 - 3:10pm | 308Life sciences company Revive Therapeutics Ltd. (OTCQB: RVVTF) is advancing its first Phase I/II clinical trial of oral psilocybin for methamphetamine use disorder treatment while also developing an oral psilocybin thin film strip product. Revive is currently studying psilocybin’s potential as...